Bio Green Energy Tech PCL Statistics
Total Valuation
BKK:BIOTEC has a market cap or net worth of THB 885.48 million. The enterprise value is 1.35 billion.
| Market Cap | 885.48M |
| Enterprise Value | 1.35B |
Important Dates
The next estimated earnings date is Wednesday, May 27, 2026.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BKK:BIOTEC has 3.05 billion shares outstanding. The number of shares has increased by 0.99% in one year.
| Current Share Class | 3.05B |
| Shares Outstanding | 3.05B |
| Shares Change (YoY) | +0.99% |
| Shares Change (QoQ) | +0.86% |
| Owned by Insiders (%) | 45.68% |
| Owned by Institutions (%) | 0.02% |
| Float | 1.06B |
Valuation Ratios
The trailing PE ratio is 11.24.
| PE Ratio | 11.24 |
| Forward PE | n/a |
| PS Ratio | 0.22 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 1.80 |
| P/FCF Ratio | 16.62 |
| P/OCF Ratio | 12.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.81, with an EV/FCF ratio of 25.32.
| EV / Earnings | 17.02 |
| EV / Sales | 0.34 |
| EV / EBITDA | 8.81 |
| EV / EBIT | 22.68 |
| EV / FCF | 25.32 |
Financial Position
The company has a current ratio of 0.59, with a Debt / Equity ratio of 0.43.
| Current Ratio | 0.59 |
| Quick Ratio | 0.31 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 3.23 |
| Debt / FCF | 9.28 |
| Interest Coverage | 2.03 |
Financial Efficiency
Return on equity (ROE) is 7.20% and return on invested capital (ROIC) is 3.17%.
| Return on Equity (ROE) | 7.20% |
| Return on Assets (ROA) | 1.50% |
| Return on Invested Capital (ROIC) | 3.17% |
| Return on Capital Employed (ROCE) | 4.16% |
| Weighted Average Cost of Capital (WACC) | 1.35% |
| Revenue Per Employee | 19.68M |
| Profits Per Employee | 394,245 |
| Employee Count | 201 |
| Asset Turnover | 1.60 |
| Inventory Turnover | 16.95 |
Taxes
In the past 12 months, BKK:BIOTEC has paid 18.11 million in taxes.
| Income Tax | 18.11M |
| Effective Tax Rate | 18.46% |
Stock Price Statistics
The stock price has increased by +52.63% in the last 52 weeks. The beta is -0.88, so BKK:BIOTEC's price volatility has been lower than the market average.
| Beta (5Y) | -0.88 |
| 52-Week Price Change | +52.63% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 0.21 |
| Relative Strength Index (RSI) | 62.53 |
| Average Volume (20 Days) | 7,097,583 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:BIOTEC had revenue of THB 3.96 billion and earned 79.24 million in profits. Earnings per share was 0.03.
| Revenue | 3.96B |
| Gross Profit | 191.44M |
| Operating Income | 59.35M |
| Pretax Income | 98.12M |
| Net Income | 79.24M |
| EBITDA | 135.06M |
| EBIT | 59.35M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 37.31 million in cash and 494.27 million in debt, with a net cash position of -456.96 million or -0.15 per share.
| Cash & Cash Equivalents | 37.31M |
| Total Debt | 494.27M |
| Net Cash | -456.96M |
| Net Cash Per Share | -0.15 |
| Equity (Book Value) | 1.15B |
| Book Value Per Share | 0.37 |
| Working Capital | -337.21M |
Cash Flow
In the last 12 months, operating cash flow was 69.84 million and capital expenditures -16.57 million, giving a free cash flow of 53.27 million.
| Operating Cash Flow | 69.84M |
| Capital Expenditures | -16.57M |
| Depreciation & Amortization | 75.71M |
| Net Borrowing | -472.98M |
| Free Cash Flow | 53.27M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 4.84%, with operating and profit margins of 1.50% and 2.02%.
| Gross Margin | 4.84% |
| Operating Margin | 1.50% |
| Pretax Margin | 2.48% |
| Profit Margin | 2.02% |
| EBITDA Margin | 3.41% |
| EBIT Margin | 1.50% |
| FCF Margin | 1.35% |
Dividends & Yields
BKK:BIOTEC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.99% |
| Shareholder Yield | -0.99% |
| Earnings Yield | 8.95% |
| FCF Yield | 6.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |